Review of bi-specific therapies in uveal melanoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
https://www.nature.com/articles/s41417-022-00442-9.pdf
Reference37 articles.
1. Grisanti S, Tura A. Uveal Melanoma. In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018. Chapter 1.
2. van der Kooij MK, Speetjens FM, van der Burg SH, Kapiteijn E. Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types. Cancers (Basel). 2019;11:845. https://doi.org/10.3390/cancers11060845.
3. Wessely A, Steeb T, Erdmann M, Heinzerling L, Vera J, Schlaak M, et al. The Role of Immune Checkpoint Blockade in Uveal Melanoma. Int J Mol Sci. 2020;21:879. https://doi.org/10.3390/ijms21030879. PMID: 32013269; PMCID: PMC7037664
4. Marseglia M, Amaro A, Solari N, Gangem R, Croce E, Tanda ET, et al. How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma. Cancers (Basel). 2021;13:2043. https://doi.org/10.3390/cancers13092043.
5. Middleton MR, McAlpine C, Woodcock VK, Corrie P, Infante JR, Steven NM, et al. Tebentafusp, a TCR/anti-CD3 bispecific fusion protein targeting gp100, potently activated anti-tumor immune responses in patients with metastatic melanoma. Clin Cancer Res. 2020;clincanres.1247.2020.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations;Pigment Cell & Melanoma Research;2024-02-27
2. From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma;Current Oncology;2024-02-01
3. The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma;Melanoma Research;2023-09-22
4. Uveal melanoma: In the era of new treatments;Cancer Treatment Reviews;2023-09
5. Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma;Cancers;2022-05-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3